http://www.proactiveinvestors.com.au Proactiveinvestors RSS feed en Mon, 22 Jan 2018 11:30:36 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - NetScientific Portfolio Update ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20180116070004_13497334/ Tue, 16 Jan 2018 18:00:04 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20180116070004_13497334/ <![CDATA[RNS press release - ProAxsis Achieves CE Mark for Plasmin Immunoassay ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20180108070005_13487715/ Mon, 08 Jan 2018 18:00:05 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20180108070005_13487715/ <![CDATA[RNS press release - GlycotestT Completes Diagnostic Evaluation ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20180104070002_13484604/ Thu, 04 Jan 2018 18:00:02 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20180104070002_13484604/ <![CDATA[RNS press release - Wanda Awarded Two Patents ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171212070006_13461627/ Tue, 12 Dec 2017 18:00:06 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171212070006_13461627/ <![CDATA[RNS press release - ProAxsis: Sales Update ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171121070009_13438235/ Tue, 21 Nov 2017 18:00:09 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171121070009_13438235/ <![CDATA[RNS press release - Vortex Announces First Commercial VTX-1 Sale ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171107070005_13422357/ Tue, 07 Nov 2017 18:00:05 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171107070005_13422357/ <![CDATA[RNS press release - HRS Expands Use of Wanda to All Patients ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171103110003_13419876/ Fri, 03 Nov 2017 22:00:03 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171103110003_13419876/ <![CDATA[RNS press release - Glycotest Adds Allowed Chinese Patent to Portfolio ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171102070006_13417611/ Thu, 02 Nov 2017 18:00:06 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171102070006_13417611/ <![CDATA[RNS press release - Vortex Announces Liquid Biopsy Study in NPJ ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171101110002_13416554/ Wed, 01 Nov 2017 22:00:02 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171101110002_13416554/ <![CDATA[RNS press release - ProAxsis Showcases ProteaseTag® Research at NACFC ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171030070005_13412479/ Mon, 30 Oct 2017 18:00:05 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171030070005_13412479/ <![CDATA[RNS press release - ProAxsis Partnership - US National Jewish Health ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171027070003_13410853/ Fri, 27 Oct 2017 17:00:03 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171027070003_13410853/ <![CDATA[RNS press release - Directorate Change ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171025070004_13407854/ Wed, 25 Oct 2017 17:00:04 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171025070004_13407854/ <![CDATA[RNS press release - Glycotest Granted Japanese Patent ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171005070005_13386614/ Thu, 05 Oct 2017 17:00:05 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171005070005_13386614/ <![CDATA[RNS press release - Wanda Awarded US Patent ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171002070007_13381643/ Mon, 02 Oct 2017 17:00:07 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20171002070007_13381643/ <![CDATA[RNS press release - 2017 Interim Results ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170928070006_13378040/ Thu, 28 Sep 2017 16:00:06 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170928070006_13378040/ <![CDATA[RNS press release - ProAxsis appoints Diagenics Limited as Distributor ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170914070007_13362278/ Thu, 14 Sep 2017 16:00:07 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170914070007_13362278/ <![CDATA[RNS press release - ProAxsis Signs Partnership: Biotechnology Company ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170911070003_13357489/ Mon, 11 Sep 2017 16:00:03 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170911070003_13357489/ <![CDATA[RNS press release - Notice of Interim Results ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170907070007_13354506/ Thu, 07 Sep 2017 16:00:07 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170907070007_13354506/ <![CDATA[RNS press release - ProAxsis is awarded a European CE Mark ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170904070006_13350009/ Mon, 04 Sep 2017 16:00:06 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170904070006_13350009/ <![CDATA[RNS press release - ProAxsis awarded a Significant Innovate UK Grant ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170724070006_13304302/ Mon, 24 Jul 2017 16:00:06 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170724070006_13304302/ <![CDATA[RNS press release - PDS Announces Clinical Collaboration with Merck ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170710120001_13289558/ Mon, 10 Jul 2017 21:00:01 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170710120001_13289558/ <![CDATA[RNS press release - Glycotest Strengthens Intellectual Property Reach ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170707070005_13287157/ Fri, 07 Jul 2017 16:00:05 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170707070005_13287157/ <![CDATA[RNS press release - Glycotest Update ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170626070005_13272166/ Mon, 26 Jun 2017 16:00:05 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170626070005_13272166/ <![CDATA[RNS press release - Result of AGM ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170621120002_13268406/ Wed, 21 Jun 2017 21:00:02 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170621120002_13268406/ <![CDATA[RNS press release - Holdings in Company ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170616100517_13263209/ Fri, 16 Jun 2017 19:05:17 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170616100517_13263209/ <![CDATA[RNS press release - Holdings in Company ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170615145224_13262119/ Thu, 15 Jun 2017 23:52:24 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170615145224_13262119/ <![CDATA[RNS press release - Results of General Meeting ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170612120203_13257134/ Mon, 12 Jun 2017 21:02:03 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170612120203_13257134/ <![CDATA[RNS press release - Result of Placing ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170612111014_13257009/ Mon, 12 Jun 2017 20:10:14 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170612111014_13257009/ <![CDATA[RNS press release - Notice of AGM and Annual Report & Accounts ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170526155251_13240726/ Sat, 27 May 2017 00:52:51 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170526155251_13240726/ <![CDATA[RNS press release - Results of Placing and Subscription ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170526124955_13240331/ Fri, 26 May 2017 21:49:55 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170526124955_13240331/ <![CDATA[RNS press release - Proposed Placing and Subscription ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170525115142_13238615/ Thu, 25 May 2017 20:51:42 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170525115142_13238615/ <![CDATA[RNS press release - Vortex Initiates Clinical Research Studies ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170524070013_13236227/ Wed, 24 May 2017 16:00:13 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170524070013_13236227/ <![CDATA[RNS press release - ProAxsis announces additional IP ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170510070011_13220019/ Wed, 10 May 2017 16:00:11 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170510070011_13220019/ <![CDATA[RNS press release - ProAxsis Presents New Data at Major US Conference ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170505070009_13215294/ Fri, 05 May 2017 16:00:09 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170505070009_13215294/ <![CDATA[RNS press release - BTG purchases Wanda's shares in Oncoverse ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170424070009_13201165/ Mon, 24 Apr 2017 16:00:09 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170424070009_13201165/ <![CDATA[RNS press release - Full Year Results for the year ended 31 Dec 2016 ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170403070010_13180114/ Mon, 03 Apr 2017 16:00:10 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170403070010_13180114/ <![CDATA[RNS press release - Vortex Biosciences Announces Publications ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170331070015_13178134/ Fri, 31 Mar 2017 17:00:15 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170331070015_13178134/ <![CDATA[RNS press release - Notice of Preliminary Results ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170327070010_13171613/ Mon, 27 Mar 2017 17:00:10 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170327070010_13171613/ <![CDATA[RNS press release - Vortex Biosciences Launches VTX-1 Liquid Biopsy ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170222070008_13135064/ Wed, 22 Feb 2017 18:00:08 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170222070008_13135064/ <![CDATA[RNS press release - Vortex Biosciences' CSO Wins SLAS Innovation Award ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170215070007_13127904/ Wed, 15 Feb 2017 18:00:07 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170215070007_13127904/ <![CDATA[RNS press release - Vortex Biosciences' CSO Finalist for SLAS Award ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170209070011_13121937/ Thu, 09 Feb 2017 18:00:11 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20170209070011_13121937/ <![CDATA[RNS press release - Netscientific: Vortex Biosciences Analysis Data ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20161118070007_013039279/ Fri, 18 Nov 2016 18:00:07 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20161118070007_013039279/ <![CDATA[Media files - NetScientific plc chief hails progress at Vortex Biosciences ]]> http://www.proactiveinvestors.com.au/companies/stocktube/6340/netscientific-plc-chief-hails-progress-at-vortex-biosciences-6340.html Mon, 07 Nov 2016 09:15:00 +1100 http://www.proactiveinvestors.com.au/companies/stocktube/6340/netscientific-plc-chief-hails-progress-at-vortex-biosciences-6340.html <![CDATA[RNS press release - Vortex Gains CE Mark and FDA Class 1 Registration ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20161103163421_013023729/ Fri, 04 Nov 2016 03:34:21 +1100 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20161103163421_013023729/ <![CDATA[RNS press release - NetScientific Interim Results ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160927070010_012979496/ Tue, 27 Sep 2016 16:00:10 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160927070010_012979496/ <![CDATA[RNS press release - Notice of Interim Results ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160906070011_012955285/ Tue, 06 Sep 2016 16:00:11 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160906070011_012955285/ <![CDATA[RNS press release - Vortex Biosciences Appoints Experts to New SAB ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160818070610_012935297/ Thu, 18 Aug 2016 16:06:10 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160818070610_012935297/ <![CDATA[RNS press release - Vortex Licenses Patents From Harvard University ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160803070009_012916737/ Wed, 03 Aug 2016 16:00:09 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160803070009_012916737/ <![CDATA[News - NetScientific investee company strikes Harvard licensing deal ]]> http://www.proactiveinvestors.com.au/companies/news/128945/netscientific-investee-company-strikes-harvard-licensing-deal-128945.html The AIM-listed healthcare technology incubator, NetScientific PLC (LON:NSCI), said one of its investee companies had struck a deal with Harvard University.

Vortex Biosciences has been granted a series of licences for cell electroporation technology developed by Harvard researchers that will boost its ability to analyse circulation tumour cells (CTCs).

The patents will also “significantly strengthen” Vortex’s intellectual property base, NetScientific said in an announcement Wednesday.

Chief executive Francois Martelet: “The exclusive license of these new patents from a world leading research institution will significantly increase the ability of Vortex's technology to characterize CTCs and strengthen its ability to analyse the underlying drivers of a patient's disease as the VTX-1 moves towards commercialisation."

The VTX-1 system, introduced earlier this year, offers one of the most sophisticated ways to collect and analyse CTCs, which provide the early, tell-tale signs of the onset of cancer.

Being able to identify and capture CTCs allows earlier intervention; it may also hold the key to a personalised approach to treating the killer disease, academic research has shown.

]]>
Wed, 03 Aug 2016 07:38:00 +1000 http://www.proactiveinvestors.com.au/companies/news/128945/netscientific-investee-company-strikes-harvard-licensing-deal-128945.html
<![CDATA[RNS press release - Change of Adviser ]]> http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160728070016_012909257/ Thu, 28 Jul 2016 16:00:16 +1000 http://www.proactiveinvestors.com.au/companies/rns/3656/LSE20160728070016_012909257/